Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Better Buy: Biogen vs. Amgen

TheMotleyFool

0 0

Better Buy: Biogen vs. AmgenPhoto, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

Choosing between biotech giants Biogen (NASDAQ: BIIB) and Amgen (NASDAQ: AMGN) is not an easy task. Both companies have attractive pipelines and solid suites of products on the market. Though Amgen's revenue declined in 2019 while Biogen's rose, Amgen offered a better revenue outlook for 2020.

Both stocks make a great addition to a biotech portfolio, but before deciding which one is the best buying opportunity right now amid all the market volatility, let's take a closer look at their sales, products, and prospects.

Image source: Getty Images.

Source Fool.com

Like: 0

AMGN

Teilen